G-12
Interleukin-12 Human, Interferon Gamma-1a
Viatrexx Bio Incorporated
Human Otc Drug
NDC 63776-694G-12 also known as Interleukin-12 Human, Interferon Gamma-1a is a human otc drug labeled by 'Viatrexx Bio Incorporated'. National Drug Code (NDC) number for G-12 is 63776-694. This drug is available in dosage form of Spray. The names of the active, medicinal ingredients in G-12 drug includes Interferon Gamma-1a - 200 [kp_C]/mL Interleukin-12 Human - 200 [kp_C]/mL . The currest status of G-12 drug is Active.
Drug Information:
| Drug NDC: | 63776-694 |
| The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. |
| Proprietary Name: | G-12 |
| Also known as the trade name. It is the name of the product chosen by the labeler. |
| Product Type: | Human Otc Drug |
| Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. |
| Non Proprietary Name: | Interleukin-12 Human, Interferon Gamma-1a |
| Also known as the generic name, this is usually the active ingredient(s) of the product. |
| Labeler Name: | Viatrexx Bio Incorporated |
| Name of Company corresponding to the labeler code segment of the ProductNDC. |
| Dosage Form: | Spray |
| The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. |
| Status: | Active |
| FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. |
| Substance Name: | INTERFERON GAMMA-1A - 200 [kp_C]/mL
INTERLEUKIN-12 HUMAN - 200 [kp_C]/mL
|
| This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. |
| Route Details: | ORAL
|
| The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
Marketing Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Marketing Category: | UNAPPROVED HOMEOPATHIC |
| Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
| Marketing Start Date: | 24 Jul, 2012 |
| This is the date that the labeler indicates was the start of its marketing of the drug product. |
| Marketing End Date: | 25 Dec, 2025 |
| This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. |
| Listing Expiration Date: | 31 Dec, 2023 |
| This is the date when the listing record will expire if not updated or certified by the firm. |
OpenFDA Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Manufacturer Name: | VIATREXX BIO INCORPORATED
|
| Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. |
| Original Packager: | Yes
|
| Whether or not the drug has been repackaged for distribution. |
| UNII: | VC9M78242P
7B590791ER
|
| Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. |
Packaging Information:
| Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
|---|
| 63776-694-15 | 1 BOTTLE, SPRAY in 1 BOX (63776-694-15) / 50 mL in 1 BOTTLE, SPRAY | 24 Jul, 2012 | N/A | No |
| Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. |
Purpose:
Purpose: interleukin 12 immune support interferon gamma immune support
Product Elements:
G-12 interleukin-12 human, interferon gamma-1a alcohol water interleukin-12 human interleukin-12 human interferon gamma-1a interferon gamma-1a
Indications and Usage:
Uses to help with symptoms of weakened immune, sensitivites and infections.
Warnings:
Warnings stop use and ask a health care practitioner if symptoms persist for more than five days or worsen. if pregnant or breastfeeding, ask a health care practitioner before use.
Dosage and Administration:
Dosage 1-5 spray(s); 1-3 time(s) per day or as recommended by your health care practitioner.
Package Label Principal Display Panel:
Principal display panel item: vp0084 ndc 63776-694-15 homeopathic remedy g-12 ⢠to help with symptoms of weakened immune, sensitivites and infections. oral spray 50ml 1.7 oz viatrexx ⢠bio incorporated manufactured by viatrexx www.viatrexx.com newark, de 19713 g-12 50 ml 1.7 oz viatrexx ⢠bio incorporated item: vp0084 ndc: 63776-694-15 indications: to help with symptoms of weakened immune, sensitivites and infections. directions: 1-5 spray(s); 1-3 time(s) per day or as recommended by your health care practitioner. mfg. for viatrexx bio incorporated. www.viatrexx.com newark, de 19713 g-12 carton ingredients
Further Questions:
Questions info@viatrexx.com